Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management

RecruitingOBSERVATIONAL

Enrollment

160

Participants

Timeline

Start Date

November 5, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions

MelanomaImmunotoxicity

Interventions

DRUG

Immunotherapy

Patients will be treated in accordance with the guidelines for melanoma treatment.

Trial Locations (2)

RECRUITING

CHU de Montpellier, Montpellier

NOT_YET_RECRUITING

Institut du Cancer de Montpellier (ICM), Montpellier

All Listed Sponsors

lead

University Hospital, Montpellier

OTHER